145 related articles for article (PubMed ID: 19696612)
1. Clinical value of morphometric and DNA flow cytometric variables as independent predictors of survival in epithelial ovarian carcinoma: a 5-year follow-up study.
Veerman MM; van der Wurff AA; van de Water M; Kruitwagen RF; Feijen HW; Vos MC
Int J Gynecol Pathol; 2009 Sep; 28(5):432-41. PubMed ID: 19696612
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic variables, operative characteristics, and DNA ploidy in predicting outcome in ovarian epithelial carcinoma.
Rice LW; Mark SD; Berkowitz RS; Goff BA; Lage JM
Obstet Gynecol; 1995 Sep; 86(3):379-85. PubMed ID: 7651646
[TBL] [Abstract][Full Text] [Related]
3. Influence of cellular DNA content on survival in ovarian carcinoma.
Klemi PJ; Joensuu H; Mäenpää J; Kiilholma P
Obstet Gynecol; 1989 Aug; 74(2):200-4. PubMed ID: 2748056
[TBL] [Abstract][Full Text] [Related]
4. Classic prognostic factors, flow cytometric data, nuclear morphometric variables and mitotic indexes as predictors in transitional cell bladder cancer.
Lipponen PK; Eskelinen MJ; Kiviranta J; Nordling S
Anticancer Res; 1991; 11(2):911-6. PubMed ID: 2064350
[TBL] [Abstract][Full Text] [Related]
5. Influence of cellular DNA content on survival in advanced ovarian cancer.
Friedlander ML; Hedley DW; Taylor IW; Russell P; Coates AS; Tattersall MH
Cancer Res; 1984 Jan; 44(1):397-400. PubMed ID: 6690054
[TBL] [Abstract][Full Text] [Related]
6. Tumour ploidy, morphometry, histological grading and clinical features in ovarian carcinoma: mutual relations.
Haapasalo H; Atkin NB; Collan Y; Pesonen E; Paljärvi L
Anal Cell Pathol; 1991 Sep; 3(5):261-71. PubMed ID: 1931753
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic and flow cytometric DNA study of medullary thyroid carcinoma.
el-Naggar AK; Ordonez NG; McLemore D; Schultz P; Hickey RC; Samaan N
Surgery; 1990 Dec; 108(6):981-5. PubMed ID: 2247844
[TBL] [Abstract][Full Text] [Related]
8. Clinical, histological and quantitative prognostic factors in cutaneous malignant melanoma.
Karjalainen J; Eskelinen M; Kosma VM; Lipponen P; Tuominen L; Alhava E
Anticancer Res; 1992; 12(5):1507-11. PubMed ID: 1444213
[TBL] [Abstract][Full Text] [Related]
9. Morphometry of gastric carcinoma: its association with patient survival, tumour stage, and DNA ploidy.
Hamilton PW; Wyatt JI; Quirke P; Watt PC; Arthur K; Ward DC; Johnston D
J Pathol; 1992 Oct; 168(2):201-8. PubMed ID: 1460537
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric analysis of nuclear DNA content in ovarian tumors. Association of ploidy with tumor type, histologic grade, and clinical stage.
Lage JM; Weinberg DS; Huettner PC; Mark SD
Cancer; 1992 Jun; 69(11):2668-75. PubMed ID: 1571896
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric DNA-ploidy analysis of synchronously occurring multiple malignant tumors of the female genital tract.
Smit VT; Fleuren GJ; van Houwelingen JC; Zegveld ST; Kuipers-Dijkshoorn NJ; Cornelisse CJ
Cancer; 1990 Oct; 66(8):1843-9. PubMed ID: 2208040
[TBL] [Abstract][Full Text] [Related]
12. Granulosa cell tumor of the ovary. Histopathologic and flow cytometric analysis with clinical correlation.
Suh KS; Silverberg SG; Rhame JG; Wilkinson DS
Arch Pathol Lab Med; 1990 May; 114(5):496-501. PubMed ID: 2334259
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of microvessel quantitation in cisplatin treated FIGO 3 and 4 ovarian cancer patients.
van Diest PJ; Zevering JP; Zevering LC; Baak JP
Pathol Res Pract; 1995 Feb; 191(1):25-30. PubMed ID: 7651929
[TBL] [Abstract][Full Text] [Related]
14. [Flow cytometric analysis of cellular DNA content in epithelial ovarian cancer].
Arai H; Izumi S; Wada T; Tsutsui F; Yamaoka K; Nozawa S
Nihon Rinsho; 1992 Oct; 50(10):2439-43. PubMed ID: 1333018
[TBL] [Abstract][Full Text] [Related]
15. Prediction of long-term survival by flow cytometric analysis of cellular DNA content in patients with advanced ovarian cancer.
Friedlander ML; Hedley DW; Swanson C; Russell P
J Clin Oncol; 1988 Feb; 6(2):282-90. PubMed ID: 3276825
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the prognostic value of morphometric features and cellular DNA content in FIGO I ovarian cancer patients.
Baak JP; Wisse-Brekelmans EC; Uyterlinde AM; Schipper NW
Anal Quant Cytol Histol; 1987 Aug; 9(4):287-90. PubMed ID: 3663312
[TBL] [Abstract][Full Text] [Related]
17. [DNA index of colorectal carcinoma and follow-up].
Grigolato P; Chioda C; Salerni B; De Nobili U; Nascimbeni R; Lojacono L; Verardi R
Pathologica; 1992; 84(1091):311-6. PubMed ID: 1465315
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of morphometry and DNA flow-cytometry features of invasive breast cancers detected by population screening: comparison with control group of hospital patients.
Uyterlinde AM; Baak JP; Schipper NW; Peterse HJ; Meijer JW; Vooys PG; Matze E
Int J Cancer; 1991 May; 48(2):173-81. PubMed ID: 2019464
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of morphometrical features and cellular DNA content in cis-platin treated late ovarian cancer patients.
Baak JP; Schipper NW; Wisse-Brekelmans EC; Ceelen T; Bosman FT; van Geuns H; Wils J
Br J Cancer; 1988 May; 57(5):503-8. PubMed ID: 3395555
[TBL] [Abstract][Full Text] [Related]
20. Importance of histologic grading in the prognosis of epithelial ovarian carcinoma.
Sorbe B; Frankendal B; Veress B
Obstet Gynecol; 1982 May; 59(5):576-82. PubMed ID: 7070728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
